Total Funding
97
94
Total FundingCorporate Round raised
Growth Score
13 pts
Heat Score
27 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2771
AriBio is a biotechnology research company that develops novel therapeutics for the treatment of neurodegenerative and infectious diseases.
- Cyrus N. Gill: Associate Director of Clinical Operations / Clinical Consultant
- Jai Jun Choung: CEO and Founder
About the Company
AriBio is a biotechnology firm dedicated to developing therapeutic solutions for neurodegenerative disorders. At AriBio, polypharmacology is strengthened by the capabilities of advanced AI technologies. Utilizing the ARIDD™ platform, the company explores extensive molecular databases, forecasting interactions that encompass various targets and
mechanisms. By harnessing AI, AriBio strives to enhance drug efficacy and broaden potential therapeutic applications. ARIDD™ serves as a drug development platform that enhances the discovery and creation of polypharmacological medications.
